- £216.81m
- £199.57m
- £95.71m
- 82
- 19
- 78
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30.9 | 29 | 44.1 | 69.7 | 95.7 |
Cost of Revenue | |||||
Gross Profit | 20.6 | 18.3 | 24 | 33.7 | 52.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 38.7 | 37.6 | 47.4 | 66 | 86.8 |
Operating Profit | -7.73 | -8.65 | -3.33 | 3.7 | 8.93 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.96 | -9.05 | -3.82 | 3.42 | 9.15 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.37 | -6.94 | -2.26 | 3.55 | 7.75 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.34 | -6.92 | -2.42 | 3.24 | 7.75 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.34 | -6.92 | -2.42 | 3.24 | 7.75 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.036 | -0.007 | 0.018 | 0.042 |
Dividends per Share |